<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="136180" id="root" date="1996-10-23" xml:lang="en">
<title>USA: Cortech trial suspension due to rat results.</title>
<headline>Cortech trial suspension due to rat results.</headline>
<dateline>DENVER 1996-10-23</dateline>
<text>
<p>Cortech Inc said Wednesday a recent suspension of Phase II clinical trials with SB-238592 -- Bradycor, a bradykinin antagonist, for the treatment of traumatic brain injury, was due to mortality in test rats.</p>
<p>Cortech said SmithKline Beecham Plc elected to suspend the trials in response to anomalous results from a small pharmacokinetic study in rats in which unexplained mortality was seen in the test animals.</p>
<p>The suspension of the trials was not based on any adverse findings in the human clinical studies, Cortech said.  </p>
<p>Nonetheless, SmithKline Beecham felt it prudent to notify the clinical investigators, directing them to suspend all ongoing clinical studies pending clarification of the situation, Cortech said.</p>
<p>Cortech said investigations to date strongly suggest that the results of the initial pharmacokinetic rat study were due to a technical issue in the preparation or administration of the dosing solutions rather than an effect of the drug substance itself.  SmithKline Beecham anticipates being able to resume the clinical program subject to final results from these studies, Cortech said.</p>
<p>In November 1995, the companies announced a collaboration to develop SB-238592 for traumatic brain injury.  Under the agreement, SmithKline Beecham is conducting the clinical trials.  -- New York Newsdesk 212-859-1610</p>
</text>
<copyright>(c) Reuters Limited 1996</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="UK">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-23"/>
  </code>
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-23"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-23"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C23">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-23"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-23"/>
  </code>
</codes>
<dc element="dc.date.created" value="1996-10-23"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1996-10-23"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="DENVER"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
